Number of Omicron cases increasing rapidly, but there is no need to panic: NK Arora Chair, India’s COVID-19 working groupThe purpose of an additional booster dose is for different objectives. Additional doses are usually offered to those who are likely to have...
02 Jan, 2022, 11.21 PM IST
Covaxin safe and immunogenic in 2-18 age group, says Bharat BiotechThe Hyderabad-based company had conducted phase-2/3, open-label, and multi-centre studies to evaluate the safety, reactogenicity, and immun...
31 Dec, 2021, 07.00 AM IST
Bharat Biotech's partner seeks Covaxin nod in US for children between 2 and 18 yearsThe US-based firm has applied for the authorisation based on the basis of the results of phase 2 and 3 clinical trials conducted on 526 chi...
06 Nov, 2021, 01.35 PM IST
In no hurry, government seeks more opinion on Covaxin for kidsNo country is administering a Covid vaccine to children as young as 2 years. US and UK have introduced vaccines for adolescents between 16 ...
15 Oct, 2021, 07.31 AM IST
Doctors welcome expert panel's suggestion on Covaxin for children; flag issue of global acceptanceAn expert panel of India's central drug authority has recommended granting emergency use authorisation to Covaxin for children in the age g...
13 Oct, 2021, 10.13 AM IST
Biocon Biologics, Serum Institute Life Sciences to expand tie-up for R&D, new vaccinesOn Thursday, Biocon had said it will offer around 15 per cent stake to Serum Institute Life Sciences at a post-money valuation of about Rs3...
18 Sep, 2021, 06.33 AM IST
Covid in India maybe entering some kind of stage of endemicity: WHO's Soumya Swaminathan"We may be entering some kind of stage of endemicity where there is low level transmission or moderate level transmission going on but we a...
24 Aug, 2021, 08.13 PM IST
‘Cadila vaccine found to be safe for children aged 12-18 years’The Ahmedabad-based company is carrying out clinical trials involving 1,000 children to test the efficacy of its vaccine against SARS-CoV-2...
27 May, 2021, 09.50 AM IST
Paediatric trials of Covaxin may begin in June: Bharat Biotech officialThe efficacy of the jab can be improved upto 100 per cent protection by the COVID-19 appropriate behaviour and following other safety proto...
24 May, 2021, 09.17 PM IST
Bharat Biotech set to begin paediatric trials of Covaxin from June“It will be a trial on children aged 2-18 years,” said Raches Ella, Bharat Bio’s head-business development and international advocacy, addr...
24 May, 2021, 11.52 AM IST
2 billion Covid jabs to be available between August & December: GovernmentThe new ambitious projections assume significant capacity expansion of the two current vaccine-makers as well as the launch of five new vac...
14 May, 2021, 07.00 AM IST
India starts vaccinating: No hospitalisation reported, major problems were delay in uploading beneficiary listsSerum Institute of India’s Covishield and Bharat Biotech’s Covaxin were deployed across the country on Saturday. Covaxin was deployed in 11...
18 Jan, 2021, 06.20 PM IST
How Krishna Ella built Bharat Biotech and why the company is at a tipping pointBharat Biotech’s Covaxin is India’s first indigenous coronavirus vaccine. The DCGI’s approval of Covaxin, despite it not having phase-3 cli...
09 Jan, 2021, 11.00 PM IST
Covishield and Covaxin: Key concerns over the two vaccinesET tries to clear some concerns around the development with experts’ views on how the two vaccines can be used for India’s public vaccinati...
05 Jan, 2021, 09.08 AM IST
Midwifing the vaccine: The When is visible but there’s much left to do on the Who and HowThe big ‘but’ butts into scalability. The usual sticking point of lab-to-arm is hugely multiplied when dealing with a totally new vaccine a...
20 Oct, 2020, 10.33 AM IST